Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.
第一作者:
Piotr P,Buszman
第一单位:
American Heart of Poland, Katowice, Poland.
作者:
主题词
可吸收性植入物(Absorbable Implants);急性冠状动脉综合征(Acute Coronary Syndrome);老年人(Aged);心血管药物(Cardiovascular Agents);冠状动脉狭窄(Coronary Stenosis);冠状动脉血栓形成(Coronary Thrombosis);无病生存(Disease-Free Survival);用药计划表(Drug Administration Schedule);药物疗法, 联合(Drug Therapy, Combination);药物洗脱支架(Drug-Eluting Stents);女(雌)性(Female);人类(Humans);发病率(Incidence);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);服药依从性(Medication Adherence);中年人(Middle Aged);心肌梗死(Myocardial Infarction);紫杉酚(Paclitaxel);血小板聚集抑制剂(Platelet Aggregation Inhibitors);波兰(Poland);聚合物(Polymers);倾向性评分(Propensity Score);假体设计(Prosthesis Design);登记(Registries);回顾性研究(Retrospective Studies);危险因素(Risk Factors);卒中(Stroke);时间因素(Time Factors);治疗结果(Treatment Outcome)
DOI
10.1002/ccd.24732
PMID
23109067
发布时间
2022-03-31
- 浏览60
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文